Company intelligence / Profile preview

CentryMed

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

CentryMed has developed a pipeline of innovative antibody drugs targeting malignant tumors and autoimmune diseases with a focus on differentiated products to avoid homogeneous competition. Their lead clinical candidate CMDE005 is an enzyme-controlled bispecific antibody targeting EGFR×CD3 with FDA IND clearance and active recruitment in early clinical trials evaluating safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy in patients with advanced solid tumors expressing EGFR.

Therapeutic areas: OncologyImmunology
Modalities: Fully human IgM antibodiesMonoclonal antibodies (mAbs)Bispecific antibodies (e.g., EGFR×CD3 bispecific antibody CMDE005)
Industry: Biotech

Partnerships

The company collaborates with pharmaceutical R&D enterprises, universities, and scientific research institutions both in China and the United States to leverage combined expertise for innovation acceleration.

Beyond the preview

Go deeper on CentryMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CentryMed.

Explore the full profile